So what happened to the blockbuster model that proved so successful in the past?
Several factors can be held accountable for driving down returns from the blockbuster model to 5%, including:
A study by pharmaceutical research firm Best Practices, LLC reveals how marketing executives at leading organizations manage resources, key marketing tactics and timely campaign activities to create blockbuster products ahead of pre-existing products.
As economic conditions continue to place downward pressures on marketing budgets, companies managing blockbuster drugs need to ensure they gain the greatest efficiencies from their promotional spending," said Paul Meade, vice president at Best Practices, LLC.
Looking ahead, Yaffe identified one product now in clinical trials that should qualify as a blockbuster
if it receives regulatory approval: Celebra, a COX-2 inhibitor for the treatment of arthritis.
Emerging Blockbusters to Treat Psychiatric Diseases
Development Status and Anticipated Launch Year of Emerging Blockbusters
Outlook: a discussion of the dangers of under-forecasting and the need to improve forecasting going forward in order to more readily identify potential blockbusters
com/reports/c32159) has announced the addition of Blockbuster
Drugs: A 2005-2014 Forecast to their offering.
Analysis of the top 17 companies' blockbuster
portfolios examining current and future share of blockbuster